Cargando…

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.

AIM: To determine induced sputum cell counts and interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-alpha) and leukotriene B4 (LTB4) levels as markers of neutrophilic inflammation in moderate persistent asthma, and to evaluate the response to inhaled steroid therapy. METHODS: Forty-five moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Basyigit, Ilknur, Yildiz, Fusun, Ozkara, Sevgiye Kacar, Boyaci, Hasim, Ilgazli, Ahmet
Formato: Texto
Lenguaje:English
Publicado: 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781566/
https://www.ncbi.nlm.nih.gov/pubmed/15545060
http://dx.doi.org/10.1080/09629350400003118
_version_ 1782131904338722816
author Basyigit, Ilknur
Yildiz, Fusun
Ozkara, Sevgiye Kacar
Boyaci, Hasim
Ilgazli, Ahmet
author_facet Basyigit, Ilknur
Yildiz, Fusun
Ozkara, Sevgiye Kacar
Boyaci, Hasim
Ilgazli, Ahmet
author_sort Basyigit, Ilknur
collection PubMed
description AIM: To determine induced sputum cell counts and interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-alpha) and leukotriene B4 (LTB4) levels as markers of neutrophilic inflammation in moderate persistent asthma, and to evaluate the response to inhaled steroid therapy. METHODS: Forty-five moderate asthmatic patients and 10 non-smoker controls were included in this study. All patients received inhaled corticosteroid (800 microg of budesonide) for 12 weeks. Before and after treatment pulmonary function tests were performed, and symptom scores were determined. Blood was drawn for analysis of serum inflammatory markers, and sputum was induced. RESULTS: Induced sputum cell counts and inflammatory markers were significantly higher in patients with asthma than in the control group. The induced sputum eosinophil counts of 12 patients (26%) were found to be less than 5%, the non-eosinophilic group, and sputum neutrophil counts, IL-8 and TNF-alpha levels were significantly higher than the eosinophilic group (neutrophil, 50+/-14% versus 19+/-10%, p<0.01). In both groups, there was a significant decrease in sputum total cell counts and serum and sputum IL-8, TNF-alpha and LTB4 levels after the treatment. There was no change in sputum neutrophil counts. Although the sputum eosinophil count decreased only in the eosinophilic subjects, there was no significant difference in inflammatory markers between the groups. The symptom scores were significantly improved after treatment, while the improvement did not reach statistical significance on pulmonary function test parameters. CONCLUSION: Notably, in chronic asthma there is a subgroup of patients whose predominant inflammatory cells are not eosinophils. Sputum neutrophil counts and neutrophilic inflammatory markers are significantly higher in these patients. In the non-eosinophilic group, inhaled steroid caused an important decrease in inflammatory markers; however, there was no change in the sputum eosinophil and neutrophil counts.
format Text
id pubmed-1781566
institution National Center for Biotechnology Information
language English
publishDate 2004
record_format MEDLINE/PubMed
spelling pubmed-17815662007-01-25 Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Basyigit, Ilknur Yildiz, Fusun Ozkara, Sevgiye Kacar Boyaci, Hasim Ilgazli, Ahmet Mediators Inflamm Research Article AIM: To determine induced sputum cell counts and interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-alpha) and leukotriene B4 (LTB4) levels as markers of neutrophilic inflammation in moderate persistent asthma, and to evaluate the response to inhaled steroid therapy. METHODS: Forty-five moderate asthmatic patients and 10 non-smoker controls were included in this study. All patients received inhaled corticosteroid (800 microg of budesonide) for 12 weeks. Before and after treatment pulmonary function tests were performed, and symptom scores were determined. Blood was drawn for analysis of serum inflammatory markers, and sputum was induced. RESULTS: Induced sputum cell counts and inflammatory markers were significantly higher in patients with asthma than in the control group. The induced sputum eosinophil counts of 12 patients (26%) were found to be less than 5%, the non-eosinophilic group, and sputum neutrophil counts, IL-8 and TNF-alpha levels were significantly higher than the eosinophilic group (neutrophil, 50+/-14% versus 19+/-10%, p<0.01). In both groups, there was a significant decrease in sputum total cell counts and serum and sputum IL-8, TNF-alpha and LTB4 levels after the treatment. There was no change in sputum neutrophil counts. Although the sputum eosinophil count decreased only in the eosinophilic subjects, there was no significant difference in inflammatory markers between the groups. The symptom scores were significantly improved after treatment, while the improvement did not reach statistical significance on pulmonary function test parameters. CONCLUSION: Notably, in chronic asthma there is a subgroup of patients whose predominant inflammatory cells are not eosinophils. Sputum neutrophil counts and neutrophilic inflammatory markers are significantly higher in these patients. In the non-eosinophilic group, inhaled steroid caused an important decrease in inflammatory markers; however, there was no change in the sputum eosinophil and neutrophil counts. 2004-08 /pmc/articles/PMC1781566/ /pubmed/15545060 http://dx.doi.org/10.1080/09629350400003118 Text en
spellingShingle Research Article
Basyigit, Ilknur
Yildiz, Fusun
Ozkara, Sevgiye Kacar
Boyaci, Hasim
Ilgazli, Ahmet
Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
title Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
title_full Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
title_fullStr Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
title_full_unstemmed Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
title_short Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
title_sort inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781566/
https://www.ncbi.nlm.nih.gov/pubmed/15545060
http://dx.doi.org/10.1080/09629350400003118
work_keys_str_mv AT basyigitilknur inhaledcorticosteroideffectsbotheosinophilicandnoneosinophilicinflammationinasthmaticpatients
AT yildizfusun inhaledcorticosteroideffectsbotheosinophilicandnoneosinophilicinflammationinasthmaticpatients
AT ozkarasevgiyekacar inhaledcorticosteroideffectsbotheosinophilicandnoneosinophilicinflammationinasthmaticpatients
AT boyacihasim inhaledcorticosteroideffectsbotheosinophilicandnoneosinophilicinflammationinasthmaticpatients
AT ilgazliahmet inhaledcorticosteroideffectsbotheosinophilicandnoneosinophilicinflammationinasthmaticpatients